A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Heparin derived dp14 saccharide ammonium salt | Heparin derived dp14 saccharide ammonium salt, a derivative of heparin, is renowned as an esteemed anticoagulant compound. It finds vital applicability in the research of antithrombotic therapeutic approaches. Synonyms: Tetradecasaccharide dp14; Tetradecasaccharide (dp14). Mole weight: ~4100 (Average). |  |
| Heparin derived dp16 saccharide ammonium salt | Heparin derived dp16 saccharide ammonium salt is a pharmaceutical compound, finding widespread application in studying conditions like deep vein thrombosand pulmonary embolism. Synonyms: Hexadecasaccharide dp16; Hexadecasaccharide (dp16). Mole weight: ~4650 (Average). | |
| Heparin derived dp18 saccharide ammonium salt | Heparin derived dp18 saccharide ammonium salt is a biomedical product used in the research of blood clotting disorders. This compound, synthesized from heparin, exhibiting anticoagulant properties. Mole weight: ~ 5200 (average). | |
| Heparin derived dp20 saccharide ammonium salt | Heparin derived dp20 saccharide ammonium salt is a sophisticated biomedical compound employed for the research of hemostatic dysfunctions and cardiovascular pathologies. Unveiling from Heparin origin, this compound exhibits anticoagulative attributes. Mole weight: ~5750 (Average). | |
| Heparin derived dp22 saccharide ammonium salt | Heparin derived dp22 saccharide ammonium salt is an intriguing derivative arising from heparin, which is a formidable anticoagulant. Imbued with an intricate dp22 saccharide configuration, this structure augments its bioactive potential. The ammonium salt manifestation of this compound begets bolstered solubility and bioavailability. Mole weight: ~6300 (Average). | |
| Heparin derived dp24 saccharide ammonium salt | Heparin-derived dp24 saccharide ammonium salt is a biomedically utilized product, serving to study blood clotting disorders. It originates from heparin and comprises dp24 saccharide ammonium salt. Mole weight: Average 6850. | |
| Heparin derived dp26 saccharide ammonium salt | Heparin derived dp26 saccharide ammonium salt is a biomedical product used in the treatment of blood clotting disorders. It is derived from heparin, a naturally occurring anticoagulant, and exhibits potent antithrombotic properties. This product helps prevent the formation of blood clots and is commonly used in the management of deep vein thrombosis, pulmonary embolism, and other related conditions. Molecular formula: C156H207N13O247S39Na52. Mole weight: 8662.29. | |
| Heparin derived dp4 saccharide | Heparin derived dp4 saccharide, a biomedical compound derived from heparin, showcases profound therapeutic potential in treating blood clotting disorders and cardiovascular ailments. With its distinctive attributes as a dp4 saccharide ammonium salt, it exemplifies great efficacy in averting thrombosis and mitigating associated complexities. Synonyms: Tetrasaccharide (dp4); D-Glucose, O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-O-2-deoxy-6-O-sulfo-2-(sulfoamino)-β-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate). CAS No. 61844-85-7. Molecular formula: C24H40N2O39S6. Mole weight: 1172.96. | |
| Heparin derived dp6 saccharide ammonium salt | Heparin derived dp6 saccharide ammonium salt is a biomedical product derived from heparin that can be used to study blood clotting disorders. This saccharide ammonium salt exhibits potent anticoagulant properties. Synonyms: Heparin hexasaccharide. Mole weight: ~1800 (Average). | |
| Heparin derived dp8 saccharide ammonium salt | Heparin derived dp8 saccharide ammonium salt is a biomedical product used in the research of thrombosand coagulation disorders. This drug, derived from heparin, exhibits anticoagulant properties by inhibiting certain clotting factors in the blood. Synonyms: Octasaccharide dp8; Octasaccharide (dp8). Mole weight: ~2400 (Average). | |
| Heparin derived Tetrasaccharide | Heparin derived Tetrasaccharide. Group: Biochemicals. Grades: Highly Purified. CAS No. 61844-85-7. Pack Sizes: 2mg, 4mg. Molecular Formula: C24H40N2O39S6, Molecular Weight: 1172.95. US Biological Life Sciences. |  Worldwide |
| Heparin disaccharide I-A trisodium salt | It is a minor component produced from heparin by heparinase II. Synonyms: alpha-DeltaUA-2S-[1->4]-GlcNAc-6S; α-δUA-2S-[1->4]-GlcNAc-6S; D-glucose, 2-(acetylamino)-2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), sodium salt (1:3); Trisodium 2-acetamido-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-D-glucose; 2-(Acetylamino)-2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-D-glucose 6-(hydrogen sulfate), sodium salt (1:3); D-Glucose, 2-(acetylamino)-2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), trisodium salt. Grade: ≥95%. CAS No. 136098-00-5. Molecular formula: C14H18NNa3O17S2. Mole weight: 605.39. | |
| Heparin disaccharide I-H trisodium salt | It is the major component from the action of heparinase II on de-N-sulfated heparin. Synonyms: Heparin unsaturated disaccharide I-H trisodium salt; alpha-DeltaUA-2S-[1->4]-GlcN-6S; Trisodium 2-amino-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-alpha-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-D-glucose; 2-Amino-2-deoxy-4-O-(4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl)-D-glucose 6-(hydrogen sulfate) trisodium salt; α-δUA-2S-[1->4]-GlcN-6S; D-Glucose, 2-amino-2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), trisodium salt. Grade: 95%. CAS No. 136098-04-9. Molecular formula: C12H16NNa3O16S2. Mole weight: 563.35. | |
| Heparin disaccharide II-A disodium salt | It is a product of the action of heparinases II and III on heparin and heparin sulfate. Synonyms: Disodium 2-acetamido-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-D-glucopyranose; 2-(Acetylamino)-2-deoxy-4-O-(4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl)-D-glucose 6-(hydrogen sulfate) disodium salt. Grade: ≥95%. CAS No. 136098-06-1. Molecular formula: C14H19NO14SNa2. Mole weight: 503.34. | |
| Heparin disaccharide II-H disodium salt | Heparin disaccharide II-H disodium salt is the major component from the action of heparinase II on de-N-sulfated heparin. Synonyms: Heparin unsaturated disaccharide II-H disodium salt; Sodium (2R,3R,4S)-2-(((2R,3S,4R,5R)-5-amino-2,4-dihydroxy-6-oxo-1-(sulfonatooxy)hexan-3-yl)oxy)-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylate; D-Glucose, 2-amino-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), sodium salt (1:2); Alpha-delta-ua-[1->4]-GlcN-6S sodium salt; D-Glucose, 2-amino-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), disodium salt. Grade: ≥98%. CAS No. 136098-02-7. Molecular formula: C12H17NNa2O13S. Mole weight: 461.31. | |
| Heparin disaccharide III-A disodium salt | It is a minor product of the action of heparinase II on heparin. Synonyms: Disodium 2-acetamido-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-D-glucopyranose; 2-(Acetylamino)-2-deoxy-4-O-(4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl)-D-glucose disodium salt. Grade: ≥95%. CAS No. 136098-11-8. Molecular formula: C14H19NNa2O14S. Mole weight: 503.34. | |
| Heparin disaccharide III-H disodium salt | It is the major component from the action of heparinase II on de-N-sulfated heparin. Synonyms: alpha-DeltaUA-2S-[1->4]-GlcN; α-δua-2s-[1→4]-glcn; Disodium 2-amino-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-D-glucopyranose; D-Glucose, 2-amino-2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-, disodium salt; 2-Amino-2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-D-glucose disodium salt. Grade: ≥95%. CAS No. 136098-01-6. Molecular formula: C12H17NNa2O13S. Mole weight: 461.31. | |
| Heparin disaccharide III-S trisodium salt | It is produced from heparin by digestion with heparinase I and II. Synonyms: Alpha-delta-ua-2s-[1->4]-glcns sodium salt; Sodium (2R,3R,4S)-4-hydroxy-3-(sulfonatooxy)-2-(((2R,3S,4R,5R)-1,2,4-trihydroxy-6-oxo-5-(sulfonatoamino)hexan-3-yl)oxy)-3,4-dihydro-2H-pyran-6-carboxylate; Trisodium 2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfonatoamino)-D-glucose; D-Glucose, 2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-, sodium salt (1:3); 2-Deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose sodium salt (1:3); D-Glucose, 2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-, trisodium salt. Grade: ≥95%. CAS No. 136098-03-8. Molecular formula: C12H16NNa3O16S2. Mole weight: 563.35. | |
| Heparin disaccharide II-S trisodium salt | It is produced from heparinase II digestion of heparin and heparin sulphate. Synonyms: 2-Deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose 6-(Hydrogen sulfate) Trisodium Salt; Alpha-delta-ua-[1->4]-glcns-6S sodium salt; Trisodium 2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-2-(sulfonatoamino)-D-glucose; D-Glucose, 2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:3); 2-Deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose 6-(hydrogen sulfate) sodium salt (1:3); D-Glucose, 2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-, 6-(hydrogen sulfate), trisodium salt. CAS No. 136098-05-0. Molecular formula: C12H16NNa3O16S2. Mole weight: 563.35. | |
| Heparin disaccharide I-P trisodium salt | It is prepared from heparin unsaturated disaccharide I-H by n-propionylation. It is a homologue of disaccharide I-A with the inclusion of a methylene group in the amide acyl group. It does not occur in nature and was devised as an internal standard for HPLC, CZE and CE analysis of heparin/heparin sulfate. It is also ideally suited as an internal standard for HLPC/CZE analysis of chondroitin series, after digestion with chondroitinases. Synonyms: Heparin unsaturated disaccharide I-P trisodium salt; (α-δUA-2S-[1→4]-GlcNCOEt-6S); 2-Deoxy-3-O-[(1R)-4-deoxyhex-4-enopyranuronosyl]-2-(propionylamino)-D-glycero-hexopyranose trisodium salt; D-Glucose, 2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-[(1-oxopropyl)amino]-, 6-(hydrogen sulfate), trisodium salt. Grade: 95%. CAS No. 149368-05-8. Molecular formula: C15H20NNa3O17S2. Mole weight: 619.42. | |
| Heparin disaccharide I-S, tetrasodium salt | It is a predominant disaccharide produced from heparin by heparinase I and II. Synonyms: 2-Deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose 6-(hydrogen sulfate) Sodium Salt; sodium (2R,3R,4S)-2-((2R,3S,4R,5R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydro-2H-pyran-3-yloxy)-4-hydroxy-3-(sulfonatooxy)-3,4-dihydro-2H-pyran-6-carboxylate; alpha-DeltaUA-2S-[1->4]-GlcNS-6S; Tetrasodium 2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-2-(sulfonatoamino)-D-glucopyranose. Grade: ≥98%. CAS No. 136098-10-7. Molecular formula: C12H15NNa4O19S3. Mole weight: 665.40. | |
| Heparin disaccharide IV-A, sodium salt | It is produced from heparin sulfate by digestion with heparinase III. Synonyms: ΔGlcAΔ(1-4)GlcNAc; sodium (2R,3R,4S)-2-((2R,3S,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylate; D-Glucopyranose, 2-(acetylamino)-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-, sodium salt (1:1); α-δ-UA-[1->4]-GLCNAC; 2-(Acetylamino)-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-D-glucose sodium salt (1:1); D-Glucose, 2-(acetylamino)-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-, monosodium salt. Grade: ≥90%. CAS No. 136098-07-2. Molecular formula: C14H20NNaO11. Mole weight: 401.30. | |
| Heparin disaccharide IV-H | It is the product of digestion of heparin sulfate and heparin by various heparinases. Synonyms: alpha-delta-UA-[1->4]-GLCN; 2-Amino-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-D-glucose; D-Glucose, 2-amino-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-. Grade: 95%. CAS No. 123228-39-7. Molecular formula: C12H19NO10. Mole weight: 337.28. | |
| Heparin disaccharide IV-S disodium salt | It is produced from heparin sulfate by digestion with heparinase III. Synonyms: Heparin unsaturated disaccharide IV-S, disodium salt; sodium (2R,3R,4S)-2-((2R,3S,4R,5R)-4,6-dihydroxy-2-(hydroxymethyl)-5-(sulfonatoamino)tetrahydro-2H-pyran-3-yloxy)-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylate; 2-Deoxy-4-O-(4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose disodium salt; 2-Deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose sodium salt (1:2); D-Glucose, 2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-, disodium salt. Grade: ≥90%. CAS No. 136098-08-3. Molecular formula: C12H17NNa2O13S. Mole weight: 461.31. | |
| Heparin Lithium | Heparin Lithium. CAS No. 9045-22-1. Product ID: 4-00060. Purity: Heparin assay ~150 units/mg. Properties: mp 158-165 °C, pH 5.5-6.5 (10% solution). |  |
| Heparin Lithium | Heparin Lithium is a mucopolysaccharide that is used primarily as an anticoagulant. Heparin binds to antithrombin III and accelerates the rate of inhibition of coagulation proteases. Synonyms: Heparin, lithium salt; Lithium acid heparin; Lithium heparin; Lithium heparinate. CAS No. 9045-22-1. | |
| Heparin lithium salt | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: N/A. CAS No. 9045-22-1. Prepack ID 36120358-1g. See USA prepack pricing. |  |
| Heparin Lithium salt | Heparin Lithium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII). Heparin Lithium salt significantly inhibits exosome-cell interactions. Uses: Scientific research. Group: Signaling pathways. CAS No. 9045-22-1. Pack Sizes: 100 mg; 500 mg. Product ID: HY-17567B. |  |
| Heparin lithium salt from porcine intestinal mucosa | Heparin lithium salt from porcine intestinal mucosa. Group: Polysaccharide. CAS No. 9045-22-1. Product ID: (2R,3S,4S,5R,6R)-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-3-methoxy-5-sulfooxyoxane-2-carboxylic acid. Molecular formula: 623.5g/mol. Mole weight: C14H25NO20S3. COC1C (C (C (OC1C (=O)O)OC2C (OC (C (C2O)NS (=O) (=O)O)OC)COS (=O) (=O)O)OS (=O) (=O)O)O. InChI=1S/C14H25NO20S3/c1-29-9-7 (17)10 (35-38 (26, 27)28)14 (34-11 (9)12 (18)19)33-8-4 (3-31-37 (23, 24)25)32-13 (30-2)5 (6 (8)16)15-36 (20, 21)22/h4-11, 13-17H, 3H2, 1-2H3, (H, 18, 19) (H, 20, 21, 22) (H, 23, 24, 25) (H, 26, 27, 28)/t4-, 5-, 6-, 7+, 8-, 9+, 10-, 11-, 13+, 14-/m1/s1. HXSDFQWQRCUQHF-IDOMHHBZSA-N. |  |
| Heparin, Lithium salt USP | Heparin, Lithium salt USP. Grades: USP. CAS No. 9045-22-1. Product ID: 8-04702. Purity: Heparin assay ≥150 units/mg. | |
| heparin lyase | This enzyme belongs to the family of lyases, specifically those carbon-oxygen lyases acting on polysaccharides. Group: Enzymes. Synonyms: heparin eliminase; heparinase. Enzyme Commission Number: EC 4.2.2.7. CAS No. 9025-39-2. Heparinase. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5106; heparin lyase; EC 4.2.2.7; 9025-39-2; heparin eliminase; heparinase. Cat No: EXWM-5106. |  |
| Heparin lyase from Bacteroides thetaiotaomicron, Recombinant | Heparin lyase is an enzyme from Bacteroides thetaiotaomicron that acts on polysaccharides containing glucuronate or iduronate residues and 1,4-α linked 2-sulfoamino-2-deoxy-6-sulfo-D-glucose residues. Group: Enzymes. Synonyms: Heparin eliminase; Heparinase; EC 4.2.2.7. Enzyme Commission Number: EC 4.2.2.7. CAS No. 9025-39-2. Purity: >90% as judged by SDS-PAGE. Heparinase. Storage: This enzyme is shipped at room temperature but should be stored at -20 °C. Form: 35 mM NaHepes buffer, pH 7.5, 750 mM NaCl, 200 mM imidazol, 3.5 mM CaCl2, 0.02% sodium azide and 25% (v/v) glycerol. Source: E. coli. Species: Bacteroides thetaiotaomicron. Heparin eliminase; Heparinase; EC 4.2.2.7. Cat No: NATE-1549. | |
| Heparinoid JP | Sodium Polyanhydromannuronic Acid Sulfate. CAS No. 391208-81-4. Product ID: 8-05139. MFCD No. MFCD01940119. | |
| Heparinoids | Danaparoid is an anticoagulant medication used primarily for the prevention and treatment of deep vein thrombosis (DVT) and other thromboembolic disorders. It is a mixture of sulfated glycosaminoglycans, including heparan sulfate, dermatan sulfate, and chondroitin sulfate, which are derived from animal tissues. Synonyms: Heparinoid; Heparinoids and Heparinlike substances; Mucopolysaccharides, heparinoids; Danaparoid; Lomoparan; OH 10172; Orgaran. CAS No. 308068-55-5. | |
| Heparinoids | Heparinoids. CAS No. 54328-33-5. Product ID: 4-00685. Properties: potential therapeutic for Alzheimer's Disease, Osteoporosis and high cholesterol and blood pressure. | |
| Heparin polyaldehyde | Heparin 2,3-dialdehyde. Product ID: 5-02132. Purity: ~0.1 m mol aldehyde per gram of heparin. | |
| Heparin Sodium | Heparin sodium is a sodium salt of heparin which is a naturally-occurring anticoagulant used for anticoagulation for cardiovascular disease. It is an inhibitor of activated coagulation factors such as Factors Xa and IIa (thrombin). Uses: Anticoagulation for cardiovascular disease. Synonyms: Adomiparin Sodium; Alfa 87-120; Ardeparin Sodium; Badyket; Bemiparin Sodium; Dalteparin Sodium; Deligoparin Sodium; Depo-Heparin; Fragmin; Hepaflush; Hepagumin; Hepalean; Heprinar; Hepsal; Lipo-Hepin; Liquaemin Sodium; Logiparin; Longheparin; Minolteparin Sodium; Monoparin; Nadroparine Sodium; Normiflo; Panheprin; Parnaparin Sodium; Pularin; Reviparin Sodium; Semuloparin Sodium; Sevuparin Sodium; Sodium Acid Heparin; Sodium Heparin; Sodium Heparinate; Thrombo-Hepin. CAS No. 9041-8-1. Molecular formula: (C12H16NS2Na3)20. Mole weight: 6000-20000. | |
| Heparin Sodium | . CAS No. 9041-8-1. Product ID: 4-00057. Mole weight: Av. Mw ~15,000. Purity: Heparin assay~160 units/mg. Source : from porcine intestinal mucosa. Reference: J. Am. Med. Assn., 266, 382, 1991. | |
| Heparin Sodium | Heparin sodium is an anticoagulant, is a kind of mucosaccharide, is extracted from the intestinal mucosa of pigs, cattle, sheep sodium salt glucosamine sulfate, in the human body is secreted by mast cells and naturally exists in the blood. Heparin sodium Chemicalbook can prevent platelet aggregation and destruction, inhibit the transformation of fibrinogen into fibrin monomer, inhibit the formation of thrombin and counter the already formed thrombin, prevent the transformation of prothrombin into thrombin and antithrombin. Synonyms: SODIUM HEPARIN;SODIUM HEPARINATE;REVIPARIN SODIUM;PORCINE HEPARIN SODIUM;BOVINE HEPARIN SODIUM;HEP, NA, BOVINE;HEP, NA, PORCINE;HEPARIN PORCINE SODIUM SALT. CAS No. 9041-8-1. Product ID: PAP-0071. Molecular formula: (C12H16NS2Na3)20. Category: Cardiovascular. Product Keywords: Cardiovascular Series; Heparin Sodium; PAP-0071; Cardiovascular; (C12H16NS2Na3)20; 9041-08-1. Standard: CP. Chemical Name: SODIUM HEPARIN;SODIUM HEPARINATE;REVIPARIN SODIUM;PORCINE HEPARIN SODIUM;BOVINE HEPARIN SODIUM;HEP, NA, BOVINE;HEP, NA, PORCINE;HEPARIN PORCINE SODIUM SALT. Grade: Pharmaceutical Grade. Solubility: H2O: 50 mg/mL, clear, faintly yellow. Storage: 2-8°C. Melting Point: >181°C (dec.). Product Description: Heparin sodium is an anticoagulant, is a kind of mucosaccharide, is extracted from the intestinal mucosa of pigs, cattle, sheep sodium salt glucosamine sulfate, in the human body is secreted by ma |  |
| Heparin sodium for assays | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. |  |
| Heparin sodium identification | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Heparin Sodium, injectable grade | Heparin Sodium, injectable grade. Grades: USP. CAS No. 9041-8-1. Product ID: 8-01378. Purity: ³150 units/mg. | |
| Heparin sodium LMW | Heparin sodium LMW. Grades: partially hydrolyzed contains terminal aldehyde. CAS No. 9041-8-1. Product ID: 4-00521. Mole weight: Av. Mw ~5,000 Da. | |
| Heparin sodium LMW | Heparin sodium LMW. CAS No. 9041-8-1. Product ID: 4-00058. Mole weight: Av. Mw ~5,000. Purity: Anti-Xa activity 100-120 units/mg. Properties: 50% suspension in PBS buffer, pH 6.5-7.550%. Source : Reference: Merck Index 11, 4898. | |
| Heparin Sodium Molecular Weight Calibrant | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Heparin sodium salt | Heparin sodium salt (Sodium heparin) is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa. Heparin sodium salt significantly inhibits exosome-cell interactions. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Sodium heparin; Sodium heparinate. CAS No. 9041-8-1. Pack Sizes: 100 mg; 500 mg; 1 g. Product ID: HY-17567A. | |
| Heparin sodium salt from porcine intestinal mucosa | 5g Pack Size. Group: Bioactive Small Molecules, Biochemicals. CAS No. 9041-8-1. Prepack ID 27109831-5g. See USA prepack pricing. | |
| Heparin sodium salt from porcine intestinal mucosa | 1g Pack Size. Group: Bioactive Small Molecules, Biochemicals. CAS No. 9041-8-1. Prepack ID 27109831-1g. See USA prepack pricing. | |
| Heparin sodium salt (Low in Ca) | Heparin sodium salt (Low in Ca) is a bioactive compound with potent anticoagulant properties that are essential in managing various blood clotting disorders, including deep vein thrombosis and pulmonary embolisms. Its unique mechanism of action involves the inhibition of blood clot formation, effectively reducing the risk of further complications. This specialized Heparin sodium salt formulation contains reduced levels of calcium, thus minimizing the potential incidence of the dreaded heparin-induced thrombocytopenia (HIT) syndrome. Complex yet highly effective, this anticoagulant therapy represents a crucial medical breakthrough in ensuring patient safety and well-being. | |
| Heparin sodium salt (MW 15kDa) | Heparin sodium salt (MW 15kDa) (Sodium heparin (MW 15kDa)) is a polymer of Heparin with the molecular weight of 15kDa. Heparin sodium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa[1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Sodium heparin (MW 15kDa); Sodium heparinate (MW 15kDa). CAS No. 9041-8-1. Pack Sizes: 100 mg; 500 mg. Product ID: HY-17567C. | |
| Heparin Sodium System Suitability | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Heparin Sodium, USP | Heparin Sodium, USP. Grades: USP. CAS No. 9041-8-1. Product ID: 8-01377. Purity: ~160 units/mg. | |
| Heparin Sodium with Oversulfated Chondroitin Sulfate | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| heparin-sulfate lyase | Does not act on N,O-desulfated glucosamine or N-acetyl-O-sulfated glucosamine linkages. Group: Enzymes. Synonyms: heparin-sulfate eliminase; heparitin-sulfate lyase; heparitinase I; heparitinase II. Enzyme Commission Number: EC 4.2.2.8. CAS No. 37290-86-1. Heparinase. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5107; heparin-sulfate lyase; EC 4.2.2.8; 37290-86-1; heparin-sulfate eliminase; heparitin-sulfate lyase; heparitinase I; heparitinase II. Cat No: EXWM-5107. | |
| Heparin-sulfate lyase from Bacteroides thetaiotaomicron, Recombinant | Heparin-sulfate lyase is an enzyme from Bacteroides thetaiotaomicron that acts on linkages between acetyl-glucosamine and uronate. Group: Enzymes. Synonyms: heparin-sulfate eliminase; heparitin-sulfate lyase; heparitinase I; heparitinase II; EC 4.2.2.8. Enzyme Commission Number: EC 4.2.2.8. CAS No. 37290-86-1. Purity: >90% as judged by SDS-PAGE. Heparinase. Mole weight: 76.7 kDa. Storage: This enzyme is shipped at room temperature but should be stored at -20 °C. Form: 35 mM NaHepes buffer, pH 7.5, 750 mM NaCl, 200 mM imidazol, 3.5 mM CaCl2, 0.02% sodium azide and 25% (v/v) glycerol. Source: E. coli. Species: Bacteroides thetaiotaomicron. heparin-sulfate eliminase; heparitin-sulfate lyase; heparitinase I; heparitinase II; EC 4.2.2.8. Cat No: NATE-1550. | |
| Heparin sulfate NS-oligosaccharide NS | Heparin sulfate NS-oligosaccharide NS. | |
| Heparin sulfate oligosaccharide NAc | Heparin sulfate oligosaccharide NAc. | |
| Heparin-tyramine | reducing terminal modified. useful precursor for glycoconjugate chemistry. Product ID: 5-02812. Reference: J. Am. Chem. Soc., 115, 10531, 1993; J. Carbohydr. Chem., 10, 377, 1991; Tetrahedron Lett., 32, 3445, 1991; Carbohydr. Res., 235, 83, 1992; J. Carbohydr. Chem., 8, 597, 1989; J. Org. Chem., 55, 5560, 1990; Bioconjugate Chem., 6, 316, 1995; Pept. Res., 2. | |
| Heparin-tyramine-fluorescein-5-isothiocyanate | reducing terminal modified. suitable for conjugation to amine-containing biomolecules or resins. Product ID: 5-02813. Properties: UV (water): lmax 278.0 nm (e 8.5 x 103) for further conjugation of aldehyde- or ketone-containing biomolecules. Reference: Bioconjugate Chem., 6, 319, 1995. | |
| Heparitin sulfate lyase | Heparitin sulfate lyase (Heparinase III) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Heparinase III. CAS No. 37290-86-1. Pack Sizes: 5 U; 10 U. Product ID: HY-P2953. | |
| Heparosan from E. coli K5 | Heparosan is an endogenous Glycosaminoglycan biosynthesized and secreted by E. coli K5. Heparosan serves as the starting carbon backbone for the chemoenzymatic synthesis of heparin, a widely used clinical anticoagulant drug. Synonyms: Heparosan; Heparosan (E. coli K5). CAS No. 152324-79-3. | |
| heparosan-glucuronate 5-epimerase | The enzyme, characterized from the giant African snail Achatina fulica, participates in the biosynthetic pathway of acharan sulfate. Unlike EC 5.1.3.17, heparosan-N-sulfate-glucuronate 5-epimerase, it shows no activity with D-glucuronate residues in heparosan-N-sulfate. Group: Enzymes. Synonyms: HG-5epi. Enzyme Commission Number: EC 5.1.3.36. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5423; heparosan-glucuronate 5-epimerase; EC 5.1.3.36; HG-5epi. Cat No: EXWM-5423. | |
| heparosan-N-sulfate-glucuronate 5-epimerase | The enzyme acts on D-glucosyluronate residues in N-sulfated heparosan polymers, converting them to L-iduronate, thus modifying the polymer to heparan-N-sulfate. The enzyme requires that at least the N-acetylglucosamine residue linked to C-4 of the substrate has been deacetylated and N-sulfated, and activity is highest with fully N-sulfated substrate. It does not act on glucuronate residues that are O-sulfated or are adjacent to N-acetylglucosamine residues that are O-sulfated at the 6 position. Thus the epimerization from D-glucuronate to L-iduronate occurs after N-sulfation of glucosamine residues but before O-sulfation. Not identical with EC 5.1.3.19 chondroitin-glucuronate 5-epimerase or with EC 5.1.3.36, heparosan-glucuronate 5-epimerase. Group: Enzymes. Synonyms: heparosan epimerase; heparosan-N-sulfate-D-gl. Enzyme Commission Number: EC 5.1.3.17. CAS No. 112567-86-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5402; heparosan-N-sulfate-glucuronate 5-epimerase; EC 5.1.3.17; 112567-86-9; heparosan epimerase; heparosan-N-sulfate-D-glucuronosyl 5-epimerase; C-5 uronosyl epimerase; polyglucuronate epimerase; D-glucuronyl C-5 epimerase; poly[(1,4)-β-D-glucuronosyl-(1,4)-N-sulfo-α-D-glucosaminyl] glucurono-5-epimerase. Cat No: EXWM-5402. | |
| Heparosan synthase from Pasteurella multocida, Recombinant | Heparosan synthase [pmHS enzyme] catalyzes transfer of GlcUA and GlcNAc to heparosan chain. Group: Enzymes. Synonyms: pmHS enzyme; PmHS2; Heparosan synthase 2. Enzyme Commission Number: EC 2.4.1.-. Purity: min 95% by SDS-PAGE. Heparosan synthase. Source: E. coli. Species: Pasteurella multocida. pmHS enzyme; PmHS2; Heparosan synthase 2; Heparosan synthase. Cat No: NATE-1487. | |
| Hepatic Differentiation Inducer, SJA710-6 (2-(4-Bromophenyl)-N-(4-fluorophenyl)-3-propyl-3H-imidazo[4,5-b]pyridin-5-amine) | A cell-permeable imidazopyridinamine compound that selectively and potently induces differentiation of mesenchymal stem cells (MSCs) into hepatocyte-like cells (~47% at 5uM). Within 14 days of treatment with SJA710-6, the differentiated cells exhibit typical morphological characteristics of hepatocytes and are able to store glycogen, secret albumin, produce urea, and uptake LDL. Also, shown to increase the mRNA levels of hepatocyte-specific genes, such as albumin, AFP, CK18, c-Met, CYP1A1, CYP2B1, HNF3beta and FoxH1. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 25mg. Molecular Formula: C??H??BrFN?. US Biological Life Sciences. | Worldwide |
| Hepatitis B Virus Core 128-140 | Hepatitis B Virus Core 128-140 is a peptide fragment of the core protein of hepatitis B virus. Synonyms: H-Thr-Pro-Pro-Ala-Tyr-Arg-Pro-Pro-Asn-Ala-Pro-Ile-Leu-OH; L-threonyl-L-prolyl-L-prolyl-L-alanyl-L-tyrosyl-L-arginyl-L-prolyl-L-prolyl-L-asparagyl-L-alanyl-L-prolyl-L-isoleucyl-L-leucine. Grade: ≥95%. CAS No. 160015-13-4. Molecular formula: C66H103N17O17. Mole weight: 1406.63. | |
| Hepatitis C virus core antigen | ~1 mg/mL, ?95% (SDS-PAGE), recombinant, expressed in E. coli. Group: Fluorescence/luminescence spectroscopy. | |
| Hepatitis C virus core antigen?Fluorescein | ~1 mg/mL, ?95% (SDS-PAGE), recombinant, expressed in E. coli. Group: Fluorescence/luminescence spectroscopy. | |
| Hepatitis C virus core antigen?Rhodamine | ~1 mg/mL, ?95% (SDS-PAGE), recombinant, expressed in E. coli. Group: Fluorescence/luminescence spectroscopy. | |
| Hepatitis C virus NS3 antigen 22kDa | 0.5-1.4 mg/mL, ?90% (SDS-PAGE), recombinant, expressed in E. coli. Group: Fluorescence/luminescence spectroscopy. | |
Our database is helping our users find suppliers everyday.
